Brain death due to neuroaspergillosis in a patient with COVID-19

Rev Esp Anestesiol Reanim. 2022 Feb 9. doi: 10.1016/j.redar.2022.01.002. Online ahead of print.


Co-infections between SARS-CoV-2 and other pathogens is an important consideration for the treatment of patients with COVID-19. Aspergillus infections are part of this consideration since they present high morbidity and mortality. We present the case of a patient with COVID-19 and Aspergillus Fumigatus coinfection that evolves with brain death due to multiple heterogeneous lesions in the brain, which after a post-mortem biopsy found pathological lesions compatible with Aspergillus.

PMID:35153337 | PMC:PMC8825302 | DOI:10.1016/j.redar.2022.01.002

Source: Industry